As Johnson & Johnson attempts to settle tens of thousands of talc lawsuits, a group of five plaintiffs filed new litigation ...

Hornet Therapeutics is on a mission to prevent and treat conditions related to the Epstein-Barr virus (EBV) with the help of ...

Nuvation Bio showcased longer-term Phase 2 data around the next-gen ROS1 inhibitor it hopes will give Pfizer and Bristol ...

When Pfizer laid out the ambitious vision for its new oncology division in February, it announced that it was taking the ...

SR One, a life sciences venture capital firm that years ago split from GSK, has raised more than $200 million for a growth ...

Nimbus Therapeutics closed one of the biggest single-drug deals in biotech, selling its TYK2 inhibitor to Takeda for $4 ...

Abstracts for the American Society of Clinical Oncology are out, with new data from Pfizer's ADC, Nimbus Therapeutics' immuno ...

The European Commission on Thursday finalized rules on how it pools expertise from across the EU to assess the effectiveness ...

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and ...

Gather Health, a primary care company headed by a former VillageMD executive, has raised $16.3 million in fresh funds, ...

Finding a way to deliver genetic medicines to the right parts of the body is one of the most technologically vexing problems ...

AstraZeneca on Thursday inked a license and option deal with the US offshoot of a Chinese-Dutch company, with an eye to ...